ISHARES GOLD TRUST GENOMICS IMMUNOLOGY AND HEALTHCARE ETF IDNA 深 滬
交易中 11-04 09:47:07 美东时间
43.34
+0.870
+2.05%
華盛通- 最 高43.38
- 今 開43.38
- 成交量 1.88万股
- 最 低 43.34
- 昨 收 42.47
- 總市值 3.40亿
- 52周最高 43.79
- 市盈率 靜 --
- 換手率 0.24%
- 52周最低 25.4391
- 委 比 -88.24%
- 總股本 785.00万
- 歷史最高 54.2614
- 量 比 24.85
- 振 幅 0.09%
- 歷史最低 16.5045
- 每 手 1
- 風險率 5.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Healthcare, biotech, pharma are key diversifiers as AI disrupts digital economy – UBS
Artificial intelligence could disrupt the digital economy in much the same way the internet once upended the physical economy, according to Ulrike Hoffmann-Burchardi, Americas CIO at UBS. In an interv...
10-13 01:00
Moderna(MRNA.US)mRNA癌症疫苗重大突破引爆市场情绪！生物科技板块估值重估可能才刚开始
生物科技行业在很大程度上受到临床事件的驱动——一项三期临床试验的成功或失败，不仅可以推动直接参与其中的公司股价大幅波动，也可能影响它们所代表的整个治疗技术类别...
08-25 11:45
Healthcare ETFs rally as Moderna nearly doubles on melanoma win
Several healthcare focused exchange traded funds advanced on Wednesday after Moderna (MRNA) shares surged nearly +100%. The move followed positive late-stage trial results for Intismeran Autogene, an ...
08-19 21:13
Biotech breakout: iShares Biotechnology ETF hits all-time high
The biotechnology sector continued its advance on Tuesday, with the iShares Biotechnology ETF (IBB) reaching a record intraday high of $179.95 as investor interest in the industry remained strong. The...
06-24 02:52
We now live in a world of rolling bubbles – analyst
The top 10 stocks in the U.S. now represent approximately 45% of total market capitalization, a level of concentration that has broken traditional market trend lines and left investors struggling to d...
06-11 00:26
JPMorgan analyst sees opportunities in healthcare and financials
Monica DiCenso, head of global investment opportunities at JPMorgan Private Bank, sees the recent market rally as an opportunity for investors to reposition portfolios toward financial (XLF) and healt...
04-15 22:44
Moderna’s rally ripples through biotech and health care ETFs
Shares of Moderna (MRNA) have surged sharply this week, drawing renewed attention to exchange traded funds with significant exposure to the U.S. pharmaceutical and biotechnology company. The stock cli...
01-23 00:12
